A detailed history of Mutual Of America Capital Management LLC transactions in Exelixis, Inc. stock. As of the latest transaction made, Mutual Of America Capital Management LLC holds 154,166 shares of EXEL stock, worth $5.59 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
154,166
Previous 166,779 7.56%
Holding current value
$5.59 Million
Previous $3.75 Million 6.75%
% of portfolio
0.04%
Previous 0.04%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$21.96 - $27.6 $276,981 - $348,118
-12,613 Reduced 7.56%
154,166 $4 Million
Q2 2024

Aug 09, 2024

SELL
$20.34 - $23.73 $282,278 - $329,324
-13,878 Reduced 7.68%
166,779 $3.75 Million
Q1 2024

May 02, 2024

SELL
$20.17 - $23.93 $234,698 - $278,449
-11,636 Reduced 6.05%
180,657 $4.29 Million
Q4 2023

Jan 26, 2024

SELL
$19.25 - $24.13 $283,071 - $354,831
-14,705 Reduced 7.1%
192,293 $4.61 Million
Q3 2023

Nov 09, 2023

SELL
$19.04 - $22.74 $568,305 - $678,743
-29,848 Reduced 12.6%
206,998 $4.52 Million
Q2 2023

Aug 11, 2023

SELL
$18.17 - $20.48 $433,009 - $488,058
-23,831 Reduced 9.14%
236,846 $4.53 Million
Q1 2023

May 04, 2023

SELL
$16.3 - $19.41 $69,144 - $82,337
-4,242 Reduced 1.6%
260,677 $5.06 Million
Q4 2022

Feb 10, 2023

BUY
$14.96 - $17.39 $95,833 - $111,400
6,406 Added 2.48%
264,919 $4.25 Million
Q3 2022

Nov 08, 2022

SELL
$15.68 - $22.27 $150,700 - $214,036
-9,611 Reduced 3.58%
258,513 $4.05 Million
Q2 2022

Aug 10, 2022

SELL
$17.44 - $23.16 $355,514 - $472,116
-20,385 Reduced 7.07%
268,124 $5.58 Million
Q1 2022

May 02, 2022

BUY
$17.03 - $22.67 $94,754 - $126,135
5,564 Added 1.97%
288,509 $6.54 Million
Q4 2021

Feb 03, 2022

BUY
$15.84 - $21.88 $82,748 - $114,301
5,224 Added 1.88%
282,945 $5.17 Million
Q3 2021

Nov 10, 2021

BUY
$16.3 - $21.14 $91,149 - $118,214
5,592 Added 2.05%
277,721 $5.87 Million
Q2 2021

Aug 06, 2021

SELL
$17.95 - $25.56 $119,205 - $169,743
-6,641 Reduced 2.38%
272,129 $4.96 Million
Q1 2021

May 13, 2021

SELL
$20.53 - $25.22 $312,322 - $383,671
-15,213 Reduced 5.17%
278,770 $6.3 Million
Q4 2020

Feb 12, 2021

BUY
$18.39 - $24.8 $119,645 - $161,348
6,506 Added 2.26%
293,983 $5.9 Million
Q3 2020

Nov 13, 2020

BUY
$20.67 - $26.94 $76,272 - $99,408
3,690 Added 1.3%
287,477 $7.03 Million
Q2 2020

Aug 06, 2020

BUY
$16.46 - $27.42 $21,496 - $35,810
1,306 Added 0.46%
283,787 $6.74 Million
Q1 2020

May 11, 2020

BUY
$14.46 - $21.8 $164,684 - $248,280
11,389 Added 4.2%
282,481 $4.86 Million
Q4 2019

Feb 11, 2020

BUY
$15.15 - $18.89 $7,787 - $9,709
514 Added 0.19%
271,092 $4.78 Million
Q3 2019

Nov 14, 2019

BUY
$17.68 - $22.65 $90,274 - $115,650
5,106 Added 1.92%
270,578 $4.79 Million
Q2 2019

Aug 12, 2019

BUY
$18.93 - $24.75 $14,595 - $19,082
771 Added 0.29%
265,472 $5.67 Million
Q1 2019

May 13, 2019

SELL
$19.6 - $24.76 $52,018 - $65,713
-2,654 Reduced 0.99%
264,701 $6.3 Million
Q4 2018

Feb 12, 2019

BUY
$13.65 - $21.8 $194,526 - $310,671
14,251 Added 5.63%
267,355 $5.26 Million
Q3 2018

Nov 13, 2018

BUY
$15.87 - $22.4 $110,407 - $155,836
6,957 Added 2.83%
253,104 $4.49 Million
Q2 2018

Aug 09, 2018

BUY
$18.56 - $22.45 $4.57 Million - $5.53 Million
246,147 New
246,147 $5.3 Million

Others Institutions Holding EXEL

About EXELIXIS, INC.


  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $11.7B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track Mutual Of America Capital Management LLC Portfolio

Follow Mutual Of America Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mutual Of America Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mutual Of America Capital Management LLC with notifications on news.